Effect of Coronavirus among Kidney Disease Patients

  • Ahmed Fadhil Idan Internist, Nephrologist, Baghdad Medical City, Iraq.
  • Ali Jasem Hashem Head, Nephrologist, Baghdad Medical City, Iraq.
  • Talib Attea Salman Nephrologist, Baghdad Medical City, Iraq.
Keywords: COVID-19, Chronic Kidney Disease (CKD), Haemodialysis (HD)


Background: COVID-19 is a novel coronavirus disease caused by the severe acute respiratory syndrome coronavirus 2. Chronic kidney disease (CKD) is associated with an increased risk of both inpatient and outpatient pneumonia.

Objective: To describe the effect of COVID-19 virus on patients with kidney disease and renal transplants and analyse the outcomes of patients at the time of the study.

Patients and Method: This is a descriptive study conducted in Baghdad Medical City, Al Shifa Center (single centre study). The study included 13 RTPCR-positive patients who were screened in the inpatient and outpatient departments. All patients received treatment according to the Iraq Ministry of Health protocol with dose adjusted as per the glomerular filtration rate (GFR).

Result: The mean age of participants was 51.46 years with males more than females. Among the positive cases, 2 had acute kidney injury (15.4%), 3 had chronic kidney diseases (23.1%), 5 had end-stage renal disease (38.5%), and 3 had had renal transplants (23.1%). 6 patients out of 13 were diabetic, 11 were hypertensive, and 1 patient had heart failure. 7 (53.8%) patients were given conservative treatment, 4 were given isolated conventional haemodialysis, and only 2 patients were kept in an intensive care unit on continuous renal replacement therapy. 2 male patients died during the treatment.

Conclusion: Chronic kidney disease is a risk factor for COVID-19 infection and more mortality and infection were found in male patients as compared to female patients in our study.

How to cite this article:
Idan AF, Hashem AJ, Salman TA. Effect of Coronavirus among Kidney Disease Patients. J Commun Dis. 2022;54(2):28-32.

DOI: https://doi.org/10.24321/0019.5138.202267


Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X,

Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features

of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-

[PubMed] [Google Scholar]

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wai L, Liu Y, Hu YH, Peng P, Wang JM, Liu

JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for

Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.

[PubMed] [Google Scholar]

Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19

infection. Lancet Infect Dis. 2020 Jul;20(7):773. [PubMed] [Google Scholar]

Kliger AS, Silberzweig J. Mitigating risk of COVID-19 in dialysis facilities. Clin J Am Soc Nephrol. 2020 May

;15(5):707-9. [PubMed] [Google Scholar]

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk factors associated with acute

respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan,

China. JAMA Intern Med. 2020 Jul 1;180(7):934-43. [PubMed] [Google Scholar]

Chou CY, Wang SM, Liang CC, Chang CT, Liu JH, Wang IK, Hsiao LC, Muo CH, Huang CC, Wang RY. Risk of

pneumonia among patients with chronic kidney disease in outpatient and inpatient settings: a nationwide

population-based study. Medicine. 2014 Dec;93(27). [PubMed] [Google Scholar]

Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest.

Dec;120(6):1883-7. [PubMed] [Google Scholar]

Park HC, Lee YK, Lee SH, Yoo KD, Jeon HJ, Ryu DR, Kim SN, Sohn SH, Chun RW, Choi KB; Korean Society of

Nephrology MERS-CoV Task Force Team. Middle East respiratory syndrome clinical practice guideline for

hemodialysis facilities. Kidney Res Clin Pract. 2017 Jun;36(2)):111-6. [PubMed] [Google Scholar]

Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, Ji W. Sensitivity of chest CT for COVID-19: comparison to

RT-PCR. Radiology. 2020 Aug;296(2):E115-7. [PubMed] [Google Scholar]

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDC Wkly. 2020 Feb 21;2(8):113. [PubMed] [Google Scholar]

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report-13, 2020.

Kobayashi T, Jung SM, Linton NM, Kinoshita R, Hayashi K, Miyama T, Anzai A, Yang Y, Yuan B, Akhmetzhanov

AR, Suzuki A, Nishiura H. Communicating the risk of death from novel coronavirus disease (COVID-19). J Clin

Med. 2020 Feb;9(2):580. [PubMed] [Google Scholar]

Read JM, Bridgen JR, Cummings DA, Ho A, Jewell CP. Novel coronavirus 2019-nCoV (COVID-19): early

estimation of epidemiological parameters and epidemic size estimates. Philos Trans R Soc Lond B Biol Sci.

;376(1829):20200265. [PubMed] [Google Scholar]